Top

Published in:

01-04-2018 | Letter to the Editor

5-aminolevulinic acid fluorescence in tumefactive demyelinating lesion

Authors: Naohisa Miyagi, Shinji Nakashima, Tetsuya Negoto, Shinichirou Mori, Satoru Komaki, Motohiro Morioka, Yasuo Sugita

Published in: Neurosurgical Review | Issue 2/2018

Excerpt

Dear Editor, …

Evers G, Kamp M, Warneke N, Berdel W, Sabel M, Stummer W, Ewelt C (2017) 5-aminolevulinic acid-induced fluorescence in primary central nervous system lymphoma. World Neurosurg 98:375–380CrossRefPubMed

Ishikawa K, Sato K, Ito T, Ozaki Y, Asanome T, Yamaguchi Y, Ishida Y, Ishizuka T, Okamura N, Fuchizaki T, Tanikawa S, Tanaka S, Nakamura H (2017) A case of tumefactive multiple sclerosis resembling malignant glioma. Jpn J Neurosurg (Tokyo) 26:688–693CrossRef

Kamp MA, Fisher I, Buhner J et al (2016) 5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression. Oncotarget 7(41):66776–66789CrossRefPubMedPubMedCentral

Miyatake S, Kuroiwa T, Kajimoto Y, Miyashita M, Tanaka H, Tsuji M (2007) Fluorescence of non-neoplastic, magnetic resonance imaging-enhancing tissue by 5-amniolevulinic acid: case report. Neurosurgery 61(5):E1101–E1104CrossRefPubMed

Nestler U, Water A, Cabre P, Manzo N (2012) A case of late-onset multiple sclerosis mimicking glioblastoma and displaying intraoperative 5-aminolevulinic acid fluorescence. Acta Neurochir 154:899–901CrossRefPubMedPubMedCentral

Neuroimmunology Group of Neurology Branch of Chinese Medical Association, Neuroimmunology Committee of Chinese Society for Immunology, Immunology Society of Chinese Stroke Association (2017) Chinese guidelines for the diagnosis and management of tumefactive demyelinating lesions of central nervous system. Chin Med J 130:1838–1850CrossRef

Steinmann J, Rapp M, Turowski B, Steiger HJ, Cornellius JF, Sabel M, Kamp MA (2017) 5-ALA fluorescence behavior of cerebral infectious and inflammatory disease. Neurosurg Rev 41(1):365–369CrossRefPubMed

Sugita Y, Terasaki M, Shigemori M, Sakata K, Morimatsu M (2001) Acute focal demyelinating disease simulating brain tumors: histopathologic guidelines for an accurate diagnosis. Neuropathology 21:25–31CrossRefPubMed

Suzuki S, Oikawa M, Ito T, Sako K, Ozaki Y, Yoshinaga T, Nishihara H, Tanaka S, Nakamura H (2008) Tumefactive multiple sclerosis: a case report. J Hokkaido Brain Res Found 12:61–64

10.

Voellger B, Klein J, Mawrin C, Firsching R (2014) 5-aminolevulinic acid (5-ALA) fluorescence in infectious disease of the brain. Acta Neurochir 156:1977–1978CrossRefPubMed

Title: 5-aminolevulinic acid fluorescence in tumefactive demyelinating lesion
Authors: Naohisa Miyagi
Shinji Nakashima
Tetsuya Negoto
Shinichirou Mori
Satoru Komaki
Motohiro Morioka
Yasuo Sugita
Publication date: 01-04-2018
Publisher: Springer Berlin Heidelberg
Published in: Neurosurgical Review / Issue 2/2018
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI: https://doi.org/10.1007/s10143-018-0958-9

At a glance: The STEP trials

Springer Medicine

5-aminolevulinic acid fluorescence in tumefactive demyelinating lesion

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2018

Significance of human chorionic gonadotropin as a predictor of resistance to standard chemo-radiotherapy for pure germinoma

Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients

Ruptured dissecting aneurysms of the A1 segment of the anterior cerebral artery: three case reports and a review of the literature

Prospective and retrospective study of videoconference telemedicine follow-up after elective neurosurgery: results of a pilot program

Risk factors for new-onset shunt-dependency after craniotomies for intracranial tumors in adult patients

Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis